Match tier
Likely match
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-15
M
Mohamed Milad
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Faculty Researcher
3 h-index
11 pubs
109 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Mohamed Milad's research interests encompass diverse areas, including the development of novel therapeutic agents and the study of plant physiology. His work has involved the design and synthesis of compounds targeting specific biological pathways, such as dual inhibitors of fatty acid biosynthesis for combating bacterial infections and derivatives acting as cytoskeleton inhibitors for melanoma treatment. Milad has also investigated methods for determining nitrogen deficiencies in maize using remote sensing techniques. His academic collaborations include work with researchers at Arkansas State University and the University of Arkansas for Medical Sciences, resulting in shared publications across various scientific disciplines. Milad's scholarly output includes 11 publications with an h-index of 3 and over 100 citations.
Metrics
- h-index: 3
- Publications: 11
- Citations: 109
Selected Publications
-
Conserved Metanephric Kidney Development and Genome Methylation in Red-Eared Slider Turtle (Trachemys scripta elegans) (2026)
-
Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection (2026)
-
Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors (2025)
-
Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors (2024)
-
Determining nitrogen deficiencies for maize using various remote sensing indices (2022)
-
Bone remineralization of lytic lesions in multiple myeloma – The Arkansas experience (2021)
-
Testing differentially methylated regions through functional principal component analysis (2021)
-
Laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass in the pediatric population: a MBSAQIP analysis (2019)
Collaboration Network
Top Collaborators
Shailesh Budhathoki
Arkansas State University
3 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection
Alexei G. Basnakian
Arkansas State University
3 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection
Mohammad A. Alam
Arkansas State University
3 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection
Sanjay Adhikary
Arkansas State University
2 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
Subrata Roy
Arkansas State University
2 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
S. Chowdhury
Arkansas State University
2 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
Amanda Stillwell
Arkansas State University (US)
2 shared publications
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
Alan J. Tackett
University of Arkansas for Medical Sciences
2 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
Nathan L. Avaritt
University of Arkansas for Medical Sciences
2 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
Gayla R. Olbricht
Missouri University of Science and Technology (US)
1 shared publication
- Testing differentially methylated regions through functional principal component analysis
Meera Mohan
University of Arkansas for Medical Sciences (US)
1 shared publication
- Bone remineralization of lytic lesions in multiple myeloma – The Arkansas experience
Manoj Kumar
University of Arkansas for Medical Sciences (US)
1 shared publication
- Bone remineralization of lytic lesions in multiple myeloma – The Arkansas experience
Rohan Samant
University of Arkansas for Medical Sciences (US)
1 shared publication
- Bone remineralization of lytic lesions in multiple myeloma – The Arkansas experience
Rudy Van Hemert
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bone remineralization of lytic lesions in multiple myeloma – The Arkansas experience
Erming Tian
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bone remineralization of lytic lesions in multiple myeloma – The Arkansas experience
Similar Researchers
Based on overlapping research topics
Amit Raj Sharma
Arkansas State University
Cancer Treatment and Pharmacology
Microbial infections and disease research
Plant Physiology and Cultivation Studies
Alexx Weaver
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Microbial infections and disease research
Cancer-related molecular mechanisms research
Alexia S. Terry
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Microbial infections and disease research
Cancer-related molecular mechanisms research
Katherine Wallis
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Metabolomics and Mass Spectrometry Techniques
Aaron J. Storey
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Metabolomics and Mass Spectrometry Techniques
Alan J. Tackett
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Metabolomics and Mass Spectrometry Techniques